Cochrane Gynaecology and Fertility vs COVID-19: Collaborating to produce the ‘PregCov-19’ living systematic review

COVID-19 is especially dangerous for at risk populations, such as pregnant women. It is critical to determine how COVID-19 affects pregnant women and their babies. A regular systematic review methodology is not sufficient to synthesise the overwhelming amount of evidence produced daily worldwide.Cochrane Gynaecology and Fertility needed to carry out a living systematic review, meaning the review would be continually updated, incorporating new studies as they become available.The ‘PregCov-19’ living systematic review project commenced at the beginning of April 2020, and latest results from the living systematic review were published in September 2020. Cochrane Gynaecology and Fertility created a webpage on the University of Birmingham website to highlight the project and make it easily accessible to pregnant women, researchers, and clinicians worldwide.Learn more about this work and what Cochrane Gynaecology and Fertility learned in the process by reading this short case story.Wednesday, January 20, 2021
Source: Cochrane News and Events - Category: Information Technology Authors: Source Type: news